SVP, Chief Medical Officer · SUPERNUS PHARMACEUTICALS, INC. · SUPERNUS PHARMACEUTICALS, INC. — Restricted Stock Unit
Side
A
Value
—
Shares
70.0K
Price
—
Executed
Oct 30, 2026
Disclosed
Nov 2, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Oct 30 executedNov 2, 2026 disclosed
SUPN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
SUPERNUS PHARMACEUTICALS, INC. — Restricted Stock Unit
Ticker
SUPN
Shares
70.0K
Price per share
$0
Execution date (reported)
Oct 30, 2026
Owned after transaction
70.0K shares
Days from execution to publication
3
What this establishes
Rubin Jonathan filed this Form 4 reporting a grant or award of SUPN on Oct 30, 2026. It became public on Nov 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, Chief Medical Officer
Rubin Jonathancik:0001836067
Issuer
SUPERNUS PHARMACEUTICALS, INC.cik:0001356576
Revision history · 0
No field has changed since this record was first ingested.
